Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Lumos Pharma
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Children's Oncology Group
Dana-Farber Cancer Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)